Search company, investor...


Founded Year



Acquired | Acquired

Total Raised




About Morphotek

Morphotek is a developer of monoclonal antibody therapeutics for cancer. The company was founded in 2000 and is based in Exton, Pennsylvania.

Headquarters Location

210 Welsh Pool Road

Exton, Pennsylvania, 19341,

United States


Missing: Morphotek's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Morphotek's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Morphotek

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Morphotek is included in 1 Expert Collection, including Pharma Supply Chain.


Pharma Supply Chain

1,258 items

Morphotek Patents

Morphotek has filed 67 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date


Related Topics




Experimental cancer drugs, Transcription factors, Clusters of differentiation, Monoclonal antibodies, Lung cancer


Application Date


Grant Date



Related Topics

Experimental cancer drugs, Transcription factors, Clusters of differentiation, Monoclonal antibodies, Lung cancer



Latest Morphotek News

Botulism Market Size Witness Huge Growth by Worldwide And Future Prospective By Top Key Players|XOMA, Merz Pharma, Morphotek, Microbiotix, Mentor Corporation

Nov 26, 2020

|XOMA, Merz Pharma, Morphotek, Microbiotix, Mentor Corporation The latest Report release from Database of Data Bridge Market Research has recently published the Global research Report Titled  Botulism Market . The study provides an overview of current statistics and future predictions of the Global Botulism Market. The study highlights a detailed assessment of the Market and displays market sizing trends by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry-validated market development data. Botulism market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a CAGR of 5.10% in the above-mentioned research forecast period. The rising prevalence of communicable diseases is the factor responsible for the growth of the botulism market. Get Free Sample PDF (including COVID19 Impact Analysis) of Botulism Market Report@ (***Our Free Sample Copy of the report gives a brief introduction to the research report outlook, TOC, list of tables and figures, an outlook to key players of the market and comprising key regions. ***) The Global Botulism Market research report assembles data collected from different regulatory organizations to assess the growth of the segments. In addition, the study also appraises the global Botulism market on the basis of topography. It reviews the macro- and microeconomic features influencing the growth of the Botulism Market in each region. Various methodological tools are used to analyze the growth of the worldwide Botulism market. The major players covered in the botulism market are: XOMA, Merz Pharma, Morphotek, Microbiotix, Mentor Corporation, Metabiologics, Valeant Pharmaceuticals, Galderma, Lanzhou Institute of Biological Products, Medytox Solutions, Allergan Botulism (or botulism poisoning) is a rare serious illness that transmits through food contact through contaminated soil or through an open wound. Botulism poisoning is due to toxin produced by a type of bacteria  clostridium botulism . These bacteria can only survive in the absence of oxygen and make spores which act as protective coatings. Botulism is rare and serious illness caused by toxin that attacks the body nerves and cause difficulty in breathing, muscle  paralysis  and sometimes can cause death. The adoption of technological advancements in healthcare industry which further led the introduction of various antitoxins and antibiotics, unhygienic consumption of food, rising patient pool with government initiatives with favourable reimbursement policies are the factors driving the growth of the botulism market. But, lack of patient awareness and inadequate knowledge about botulism, unaffordability of treatment in middle income countries are the factors restraining the global botulism market. Additionally, significant investment required for treatment of botulism for availability of new solutions and diagnosis of rare disease provides an opportunistic market growth for the development of the botulism market. This botulism market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info botulism market contact Data Bridge Market Research for an  Analyst Brief,  our team will help you take an informed market decision to achieve market growth. The Botulism report study has Three major sections which include: Section 1: Market Introduction This section deals with the Botulism market definition or the market along with the target audience of the market. Later in the chapters, the research methodologies and the market tools that were used for the market analysis is mentioned. Section 2: Botulism Market DROC The flow of this section is: Botulism market growth factors and limitations. In the later chapters, the Botulism market opportunities and challenges are described. All the points mentioned within the report are updated based on the COVID-19 situation. Section 3: Conclusion and Observations Last section of the report includes comments and observations by the research analysts and the market experts for the Botulism market. Get Table Of Contents of This Premium Research For Free: Botulism Market Scope and Market Size The botulism market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets. On the basis of type, the botulism market is segmented into infant botulism, foodborne botulism, wound botulism and iatrogenic botulism. On the basis of treatment, the botulism market is segmented into antitoxin, antibiotics, rehabilitation and breathing assistance. On the basis of route of administration, the botulism market is segmented into oral,  parenteral and others. On the basis of end-users, the botulism market is segmented into  hospitals , specialty clinics and others. On the basis of distribution channel, the botulism market has also been segmented into hospital pharmacy, retail pharmacy and others. How Does This Market Insights Help? Botulism Market share (regional, product, application, end-user) both in terms of volume and revenue along with CAGR Key parameters which are driving this market and restraining its growth What all challenges manufacturers will face as well as new opportunities and threats faced by them Learn about the market strategies that are being adopted by your competitors and leading organizations To gain insightful analyses of the market and have a comprehensive understanding of the “Botulism Market” and its commercial landscape Key Pointers Covered in the Botulism Market Industry Trends and Forecast  Market Size Recent Developments for Market Competitors Market upcoming applications Current and future of global Botulism market outlook in the developed and emerging markets The segment that is expected to dominate the market as well as the segment which holds the highest CAGR in the forecast period Regions/Countries that are expected to witness the fastest growth rates during the forecast period The latest developments, market shares, and strategies that are employed by the major market players Market Dynamics: The Botulism report also demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead. It also studies the key markets and mentions the various regions i.e. the geographical spread of the industry. TABLE OF CONTENTS Part 16: Appendix In conclusion, the Botulism Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability investigation and venture return investigation. Get Enquiry About This Comprehensive Report: Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Customization of the Report: Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs. Why Is Data Triangulation Important In Qualitative Research? This involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. Triangulation is one method used while reviewing, synthesizing and interpreting field data. Data triangulation has been advocated as a methodological technique not only to enhance the validity of the research findings but also to achieve ‘completeness’ and ‘confirmation’ of data using multiple methods About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process. Contact: UK: +44 208 089 1725 Hong Kong: +852 8192 7475

Morphotek Frequently Asked Questions (FAQ)

  • When was Morphotek founded?

    Morphotek was founded in 2000.

  • Where is Morphotek's headquarters?

    Morphotek's headquarters is located at 210 Welsh Pool Road, Exton.

  • What is Morphotek's latest funding round?

    Morphotek's latest funding round is Acquired.

  • How much did Morphotek raise?

    Morphotek raised a total of $78M.

  • Who are the investors of Morphotek?

    Investors of Morphotek include Eisai, Burrill & Company, Flagship Pioneering, CB Health Ventures, Rock Maple Ventures and 12 more.

  • Who are Morphotek's competitors?

    Competitors of Morphotek include Humanetics, Synapsin Pharmaceuticals, CoMentis, Azevan Pharmaceuticals, Conatus Pharmaceuticals and 12 more.

Compare Morphotek to Competitors


Humanetics is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs. It has a focus on radiation modulators for oncology, medical imaging, and medical countermeasure uses. The company develops BIO 300, a highly selective modulator of inflammation, cell cycle arrest, and DNA damage repair. Humanetics was founded in 1988 and is based in Minneapolis, Minnesota.

NeuroMolecular Pharmaceuticals

NeuroMolecular Pharmaceuticals is developing and commercializing superior neuroprotective medicines for the treatment of central nervous system (CNS) disorders. The Company has built a robust pipeline of neuropsychiatric products based upon its scientists' unique understanding of glutamate's central role in mediating CNS disorders. NeuroMolecular is rapidly advancing its next-generation medicines into clinical studies, with preclinical programs underway in depression, pain, Alzheimer's disease, Parkinson's disease, multiple sclerosis and epilepsy. NeuroMolecular is initially focusing on the development of superior derivatives and dosage formulations of memantine, a drug recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer's disease.

Q Therapeutics

Q Therapeutics, Inc. is developing glial cell-based therapeutic products for central nervous system disorders in which a disease or injury inhibits normal myelin growth and enzyme performance.

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physicians in the treatment of neurodegenerative diseases. The Company is collaborating with global ALS specialists and seeking input from patient advocacy organizations to help inform the clinical development path and better understand the needs of people affected by the disease.

Azevan Pharmaceuticals

Azevan Pharmaceuticals is a clinical stage, small molecule drug development company developing novel therapeutics to treat disorders of stress, mood, and behavior. The Company's first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and Major Depression. Vasopressin receptor antagonists represent a novel mechanism of action for addressing these indications.


Neuronascent is focused on the discovery and development of therapies for Alzheimer's disease, depression, and stroke based on the science of neurogenesis that: (1) Reduce the loss of neurons (2) Restore and replace damaged neurons (3) Promote the formation of new neurons (4) Reverse cognitive loss

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.